{"public_id":"cl_66bb9189b6c9c52abc6c77c5c8b8ed27","status":"active","superseded_by_public_id":null,"corpus_id":82519947,"text":"Astrocyte-targeted IFN-α1 expression greatly decreases the establishment of HSV-1 latency and seroconversion after ocular infection.","confidence":0.98,"paper":{"corpus_id":82519947,"title":"Astrocyte-Targeted Expression of IFN-α1 Protects Mice from Acute Ocular Herpes Simplex Virus Type 1 Infection","url":"https://sah.borca.ai/papers/82519947"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_4a0506ff2d0275f8fa37252d29eb6a21","name":"herpes simplex virus type 1 latency","description":"The latent, persistent state of HSV-1 in host tissue after acute infection.","types":["infection state","outcome"],"url":"https://sah.borca.ai/concepts/co_4a0506ff2d0275f8fa37252d29eb6a21"},{"public_id":"co_dc1164cbb148cfab0e91ccea53079013","name":"astrocyte-targeted IFN-α1 expression","description":"Expression of the IFN-α1 transgene driven by the glial fibrillary acidic protein promoter in astrocytes.","types":["genetic construct","transgenic model"],"url":"https://sah.borca.ai/concepts/co_dc1164cbb148cfab0e91ccea53079013"},{"public_id":"co_f162d05e3ba7f6b16abdacd55d89a277","name":"seroconversion","description":"The development of detectable virus-specific antibodies in serum after infection.","types":["immune outcome","measurement"],"url":"https://sah.borca.ai/concepts/co_f162d05e3ba7f6b16abdacd55d89a277"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_66bb9189b6c9c52abc6c77c5c8b8ed27"}